Combined effects of PLK1 and RAS in hepatocellular carcinoma reveal rigosertib as promising novel therapeutic “dual-hit” option-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combined effects of PLK1 and RAS in hepatocellular carcinoma reveal rigosertib as promising novel therapeutic “dual-hit” option

Published:2017-12-11 Issue:3 Volume:9 Page:3605-3618
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Dietrich Peter¹,Freese Kim¹,Mahli Abdo¹,Thasler Wolfgang Erwin²,Hellerbrand Claus¹³,Bosserhoff Anja Katrin¹³

Affiliation:

1. Institute of Biochemistry, Emil-Fischer-Zentrum, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany

2. Biobank o.b. HTCR, Department of General Visceral- and Transplantation Surgery, Ludwig-Maximilians-University München, München, Germany

3. Comprehensive Cancer Center (CCC) Erlangen-EMN, Erlangen, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PLK1 inhibitors as a new targeted treatment for adrenocortical carcinoma;Endocrine Connections;2023-11-22

2. Establishment and verification of a prognostic risk score model based on immune genes for hepatocellular carcinoma in an Asian population;Translational Cancer Research;2023-10

3. Development of a prognostic signature based on anoikis-related genes in hepatocellular carcinoma with the utilization of LASSO-cox method;Medicine;2023-07-21

4. Lights and Shadows on the Cancer Multi-Target Inhibitor Rigosertib (ON-01910.Na);Pharmaceutics;2023-04-13

5. Using chitosan-stabilized, hyaluronic acid-modified selenium nanoparticles to deliver CD44-targeted PLK1 siRNAs for treating bladder cancer;Nanomedicine;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3